Teva Pharmaceuticals has finally launched its generic version of Mylanâs EpiPen. The Petah, Tikvah, Israel-based companyâs emergency allergy shot will be priced at $300 â the same as Mylanâs generic. Teva received approval for its version of EpiPen in August. The generic will be available in limited supply and the company will launch a lower-dose - the EpiPen Jr. sometime next year, the company said. âWeâre pleased to provide access to Epinephrine Injection (Auto-Injector) for patients who may experience life-threatening allergic emergencies and weâre fully dedicated toward ensuring additional supply in 2019,â Brendan Oâ...
MedWorm Message: Have you tried our new medical search engine? More powerful than before. Log on with your social media account. 100% free.
from #Head and Neck by Sfakianakis via simeraentaxei on Inoreader https://ift.tt/2Av2EWZ
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Σημείωση: Μόνο ένα μέλος αυτού του ιστολογίου μπορεί να αναρτήσει σχόλιο.